Statements (69)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquired_by |
gptkb:public_company
|
| gptkbp:acquisition |
gptkb:Lifespan_Biosciences
Human Longevity, Inc. acquired by a private equity firm |
| gptkbp:ceo |
gptkb:Bob_Kain
|
| gptkbp:collaboration |
gptkb:scientific_community
|
| gptkbp:focus |
healthcare
genomics |
| gptkbp:focus_area |
gptkb:health_services
gptkb:AI_technology telemedicine biomarker discovery chronic disease management clinical trials data privacy patient engagement patient-centered care data science clinical research genetic research biomedical research biostatistics regenerative medicine wellness pharmacogenomics cellular aging healthcare analytics digital health aging research epigenetics health informatics healthcare innovation healthcare accessibility preventive medicine lifestyle interventions clinical genomics digital therapeutics patient data security microbiome research health data management health analytics nutrigenomics |
| gptkbp:founded |
gptkb:2013
|
| gptkbp:founder |
gptkb:J._Craig_Venter
|
| gptkbp:goal |
extend human lifespan
improve healthspan |
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Human Longevity, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:investment |
$70 million
|
| gptkbp:location |
gptkb:California
|
| gptkbp:number_of_employees |
over 100
|
| gptkbp:partnership |
gptkb:National_Institutes_of_Health
gptkb:University_of_California,_San_Diego |
| gptkbp:product |
gptkb:HLI_Health_Nucleus
health insights genomic data platform |
| gptkbp:research |
age-related diseases
personalized medicine genetic predisposition biomarkers of aging |
| gptkbp:services |
data analysis
genomic sequencing |
| gptkbp:technology |
gptkb:Artificial_Intelligence
gptkb:machine_learning |
| gptkbp:type |
private company
|
| gptkbp:website |
humanlongevity.com
|
| gptkbp:bfsParent |
gptkb:Peter_Diamandis
|
| gptkbp:bfsLayer |
4
|